Cargando…

Toxin and Immunotoxin Based Therapeutic Approaches

Detalles Bibliográficos
Autores principales:	Bortolotti, Massimo, Polito, Letizia, Bolognesi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778363/ https://www.ncbi.nlm.nih.gov/pubmed/35051040 http://dx.doi.org/10.3390/toxins14010063

Ejemplares similares

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview
por: Polito, Letizia, et al.
Publicado: (2016)

Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2011)

High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
por: Bortolotti, Massimo, et al.
Publicado: (2016)

Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
por: Polito, Letizia, et al.
Publicado: (2017)

Ricin: An Ancient Story for a Timeless Plant Toxin
por: Polito, Letizia, et al.
Publicado: (2019)

Primary Sequence and 3D Structure Prediction of the Plant Toxin Stenodactylin
por: Iglesias, Rosario, et al.
Publicado: (2020)

Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013)

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
por: Mercatelli, Daniele, et al.
Publicado: (2020)

Antibody Based Delivery of Toxins and Other Active Molecules for Cancer Therapy
por: Polito, Letizia
Publicado: (2022)

Editorial: Toxic Plant Proteins as Experimental Drugs for Human Pathologies
por: Polito, Letizia, et al.
Publicado: (2021)

Xanthine oxidoreductase in cancer: more than a differentiation marker
por: Battelli, Maria Giulia, et al.
Publicado: (2015)

Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects
por: Battelli, Maria Giulia, et al.
Publicado: (2016)

Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research
por: Bolognesi, Andrea, et al.
Publicado: (2017)

Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
por: Battelli, Maria Giulia, et al.
Publicado: (2018)

Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a  Detoxifying Enzyme
por: Battelli, Maria Giulia, et al.
Publicado: (2016)

Pro-Aging Effects of Xanthine Oxidoreductase Products
por: Battelli, Maria Giulia, et al.
Publicado: (2020)

Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
por: Polito, Letizia, et al.
Publicado: (2021)

Xanthine oxidoreductase: One enzyme for multiple physiological tasks
por: Bortolotti, Massimo, et al.
Publicado: (2021)

Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
por: Zanello, Andrea, et al.
Publicado: (2022)

New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents
por: Bortolotti, Massimo, et al.
Publicado: (2023)

Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives
por: Mercatelli, Daniele, et al.
Publicado: (2018)

Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)

Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
por: Bortolotti, Massimo, et al.
Publicado: (2019)

Saporin-S6: A Useful Tool in Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2013)

Ribosome-Inactivating Proteins from Plants: A Historical Overview
por: Bolognesi, Andrea, et al.
Publicado: (2016)

Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine
por: Polito, Letizia, et al.
Publicado: (2016)

From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity?
por: Ardini, Matteo, et al.
Publicado: (2022)

Survival and death of intestinal cells infected by Chlamydia trachomatis
por: Foschi, Claudio, et al.
Publicado: (2019)

Immunotoxins: From Design to Clinical Application
por: Kreitman, Robert J., et al.
Publicado: (2021)

Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii
por: Bortolotti, Massimo, et al.
Publicado: (2021)

Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
por: Polito, Letizia, et al.
Publicado: (2021)

Protein Synthesis Inhibition Activity by Strawberry Tissue Protein Extracts during Plant Life Cycle and under Biotic and Abiotic Stresses
por: Polito, Letizia, et al.
Publicado: (2013)

Synergistic immunotoxin-paclitaxel combination against lymphoma
por: Müller, Fabian
Publicado: (2017)

Sequence, Structure, and Binding Site Analysis of Kirkiin in Comparison with Ricin and Other Type 2 RIPs
por: Maiello, Stefania, et al.
Publicado: (2021)

Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin.
por: Chignola, R., et al.
Publicado: (1995)

Evaluation of Hydra HALT-1 as a toxin moiety for recombinant immunotoxin
por: Jiemy, William F., et al.
Publicado: (2020)

B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.
por: Vooijs, W. C., et al.
Publicado: (1997)

Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin
por: Havaei, Seyed Mehdi, et al.
Publicado: (2021)

Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers
por: Fuchs, Hendrik, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_17cmm2iml5i5gl9om1p299so5r